121 related articles for article (PubMed ID: 15738599)
1. [Markers of bone formation in children with osteosarcoma].
Gajewska J; Ambroszkiewicz J; Rychlowska-Pruszynska M; Laskowska-Klita T
Med Wieku Rozwoj; 2004; 8(2 Pt 1):235-43. PubMed ID: 15738599
[TBL] [Abstract][Full Text] [Related]
2. [Biochemical bone resorption markers in children with osteosarcoma].
Ambroszkiewicz J; Gajewska J; Laskowska-Klita T; Woźniak W
Med Wieku Rozwoj; 2004; 8(2 Pt 1):225-33. PubMed ID: 15738598
[TBL] [Abstract][Full Text] [Related]
3. [Biochemical bone turnover markers in patients with conventional and nonconventional osteosarcoma].
Ambroszkiewicz J; Gajewska J; Klepacka T; Bilska K; Woźniak W; Laskowska-Klita T
Pol Merkur Lekarski; 2006 Oct; 21(124):330-4. PubMed ID: 17205770
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma.
Ambroszkiewicz J; Gajewska J; Klepacka T; Chełchowska M; Laskowska-Klita T; Woźniak W
Adv Med Sci; 2010; 55(2):266-72. PubMed ID: 21084254
[TBL] [Abstract][Full Text] [Related]
5. Serum bone turnover markers in patients with primary bone tumors.
Wang J; Pei F; Tu C; Zhang H; Qiu X
Oncology; 2007; 72(5-6):338-42. PubMed ID: 18187955
[TBL] [Abstract][Full Text] [Related]
6. [Serum osteocalcin and bone alkaline phosphatase in healthy children in relation to age and gender].
Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
Med Wieku Rozwoj; 2002; 6(3):257-65. PubMed ID: 12637780
[TBL] [Abstract][Full Text] [Related]
7. The levels of bone alkaline phosphatase (BALP) and soluble epidermal growth factor receptor-2 (ECD/HER-2) in pediatric patients with osteosarcoma during clinical treatment.
Rychłowska-Pruszyńska M; Gajewska J; Ambroszkiewicz J; Karwacki M; Szamotulska K
Dev Period Med; 2018; 22(1):58-64. PubMed ID: 29641422
[TBL] [Abstract][Full Text] [Related]
8. [A comparison of serum concentrations of biochemical bone turnover markers in patients with osteosarcoma with good and poor prognosis].
Ambroszkiewicz J; Gajewska J; Klepacka T; Chełchowska M; Laskowska-Klita T; Woźniak W
Pol Merkur Lekarski; 2010 Jul; 29(169):19-26. PubMed ID: 20712242
[TBL] [Abstract][Full Text] [Related]
9. Serum markers of bone turnover in children and adolescents with classic galactosemia.
Gajewska J; Ambroszkiewicz J; Radomyska B; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Milanowski A
Adv Med Sci; 2008; 53(2):214-20. PubMed ID: 18650146
[TBL] [Abstract][Full Text] [Related]
10. Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma.
Liu PP; Leung KS; Kumta SM; Lee KM; Fung KP
Oncology; 1996; 53(4):275-80. PubMed ID: 8692530
[TBL] [Abstract][Full Text] [Related]
11. [Biochemical markers of bone formation activity in children with neoplasms].
Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas P; Siedlecka E; Wiśniewska M; Wołczyński S
Wiad Lek; 2005; 58(1-2):29-35. PubMed ID: 15991550
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of pyridinium cross-links and serum osteocalcin levels in patients with primary high-grade osteosarcoma.
Ferrari S; Zolezzi C; Pratelli L; Fasano MC; Bacci G
Calcif Tissue Int; 2003 Jul; 73(1):1-4. PubMed ID: 14506946
[TBL] [Abstract][Full Text] [Related]
13. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
Koizumi M; Yonese J; Fukui I; Ogata E
J Urol; 2002 Apr; 167(4):1863-6. PubMed ID: 11912449
[TBL] [Abstract][Full Text] [Related]
14. Plasma proteome predicts chemotherapy response in osteosarcoma patients.
Li Y; Dang TA; Shen J; Hicks J; Chintagumpala M; Lau CC; Man TK
Oncol Rep; 2011 Feb; 25(2):303-14. PubMed ID: 21165584
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of selected cytokines in children and adolescents with osteosarcoma at diagnosis - preliminary report].
Markiewicz K; Zeman K; Kozar A; Gołebiowska-Wawrzyniak M
Med Wieku Rozwoj; 2011; 15(1):25-31. PubMed ID: 21786509
[TBL] [Abstract][Full Text] [Related]
16. Osteocalcin is not a marker of progress in multiple myeloma. Le Groupe d'Etude et de Recherche sur le Myélome (GERM).
Mejjad O; Le Loët X; Basuyau JP; Ménard JF; Jego P; Grisot C; Daragon A; Grosbois B; Euller-Ziegler L; Monconduit M
Eur J Haematol; 1996; 56(1-2):30-4. PubMed ID: 8599990
[TBL] [Abstract][Full Text] [Related]
17. Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone disease.
Piovesan A; Berruti A; Torta M; Cannone R; Sperone P; Panero A; Gorzegno G; Termine A; Dogliotti L; Angeli A
Calcif Tissue Int; 1997 Nov; 61(5):362-9. PubMed ID: 9351876
[TBL] [Abstract][Full Text] [Related]
18. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
Boussen H; Mezzi F; Gamoudi A; Daldoul O; Ben Hamida H; Mezlini A; Khalfallah S; Karray S; Ben Romdhane K; Ben Ghachem M; Ben Abdallah M; Douik M; Saadi A; Ben Ayed F; Ben Hassine H
Bull Cancer; 2000 Feb; 87(2):183-8. PubMed ID: 10705289
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of bone markers for detection of bone metastases in lung cancer patients.
Alataş F; Alataş O; Metintaş M; Colak O; Erginel S; Harmanci E
Clin Biochem; 2002 Jun; 35(4):293-6. PubMed ID: 12135691
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]